Significance of sentinel lymph node biopsy in malignant melanoma: Overview of international data

International Journal of Clinical Oncology

Volumn 14, Issue 6, 2009, Pages 485-489

  Moroi, Yoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Lymph node dissection; Melanoma; Prognostic value; Sentinel lymph node biopsy; Staging tool; Therapeutic effect

Indexed keywords

EOSIN; GLYCOPROTEIN GP 100; HEMATOXYLIN; INDOCYANINE GREEN; ISOSULFAN BLUE; MELAN A; MELANOMA ANTIGEN 3; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; TRANSCRIPTION FACTOR PAX3;

CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; DIAGNOSTIC PROCEDURE; DISEASE FREE SURVIVAL; FLUORESCENCE; FOLLOW UP; GOLD STANDARD; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MICROMETASTASIS; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN CANCER; SURVIVAL; SURVIVAL RATE; TUMOR CELL; TUMOR VOLUME;

HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 72949087799     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0942-z     Document Type: Review

References (34)

1. U. Veronesi J. Adamus D.C. Bandiera, et al. 1977 Inefficacy of immediate node dissection in stage 1 melanoma of the limbs N Engl J Med 297 627 630 1:STN:280:DyaE2s3lsVyrsA%3D%3D 895764
2. F.H. Sim W.F. Taylor J.C. Ivins, et al. 1978 A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma Preliminary results. Cancer 41 948 956 1:STN:280: DyaE1c7ks1agsw%3D%3D
3. C.M. Balch S. Soong M.I. Ross, et al. 2000 Long-term results of a multiinstitutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0-4.0 mm). Intergroup Melanoma Surgical Trial Ann Surg Oncol 7 87 97 10.1007/s10434-000-0087-9 1:STN:280:DC%2BD3c3it1ChsQ%3D%3D 10761786
4. N. Cascinelli A. Morabito M. Santinami, et al. 1998 Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial WHO Melanoma Programme. Lancet 351 793 796 1:STN:280: DyaK1c7nvVOksQ%3D%3D
5. D.L. Morton D.R. Wen J.H. Wong, et al. 1992 Technical details of intraoperative lymphatic mapping for early-stage melanoma Arch Surg 127 392 399 1:STN:280:DyaK383hsFWjsw%3D%3D 1558490
6. W.R. Wrightson S.L. Wong M.J. Edwards, et al. 2003 Complications associated with sentinel lymph node biopsy for melanoma Ann Surg Oncol 10 676 680 10.1245/ASO.2003.10.001 12839853 (Pubitemid 40486900)
7. D.L. Morton D.S.B. Hoon A.J. Cochran, et al. 2003 Lymphatic mapping and sentinel lymphadenectomy for early stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases Ann Surg 238 538 549 14530725
8. M. Fujiwara T. Mizukami A. Suzuki, et al. 2009 Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience J Plast Reconstr Aesthet Surg 62 373 378 10.1016/j.bjps.2007.12.074
9. C.M. Balch A.C. Buzaid M.B. Atkins, et al. 2000 A new American Joint Committee on Cancer staging system for cutaneous melanoma Cancer 88 1484 1491 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D 1:STN:280:DC%2BD3c7otlGgtg%3D%3D 10717634 (Pubitemid 30155189)
10. J.E. Gershenwald W. Thompson P.F. Mansfield, et al. 1999 Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 976 983 1:STN:280:DyaK1M7mvVymsg%3D%3D 10071292
11. M.G. Statius Muller P.A. van Leeuwen E.S. de Lange-De Klerk, et al. 2001 The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma Cancer 91 2401 2408 10.1002/1097-0142(20010615)91:12<2401::AID-CNCR1274>3.0.CO;2-I 1:STN:280:DC%2BD3MzkvFGqsg%3D%3D 11413531 (Pubitemid 32552828)
12. A.M. Eggermont U. Keilholz A. Testori, et al. 2001 The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer Ann Surg Oncol 8 9Suppl 38S 40S 1:STN:280:DC%2BD3Mrlt12lug%3D%3D 11599896
13. J.F. Thompson 2001 The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma Ann Surg Oncol 8 9Suppl 44S 47S 1:STN:280:DC%2BD3Mrlt12ksg%3D%3D 11599898
14. D.L. Morton J.F. Thompson A.J. Cochran, et al. 2006 Sentinelnode biopsy or nodal observation in melanoma N Engl J Med 355 1307 1317 10.1056/NEJMoa060992 1:CAS:528:DC%2BD2sXisVaqtr4%3D 17005948 (Pubitemid 44465459)
15. S. Debarbieux G. Duru S. Dalle, et al. 2007 Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection Br J Dermatol 157 58 67 10.1111/j.1365-2133.2007.07937.x 1:STN:280:DC%2BD2szmtlKlsw%3D%3D 17501957 (Pubitemid 46934258)
16. Ghaferi AA, Wong SL, Johnson TM, et al. (2009) Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol [Epub ahead of print]
17. C. Ariyan M.S. Brady M. Gönen, et al. 2009 Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma Ann Surg Oncol 16 186 190 10.1245/s10434-008-0187-5 18979135
18. B.E. Wright R.P. Scheri X. Ye, et al. 2008 Importance of sentinel lymph node biopsy in patients with thin melanoma Arch Surg 143 892 899 10.1001/archsurg.143.9.892 18794428
19. S.C. Shivers X. Wang W. Li, et al. 1998 Molecular staging of malignant melanoma: correlation with clinical outcome JAMA 280 1410 1415 10.1001/jama.280.16.1410 1:STN:280:DyaK1M%2FhsFKiuw%3D%3D 9801000 (Pubitemid 28496047)
20. H. Takeuchi D.L. Morton C. Kuo, et al. 2004 Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients J Clin Oncol 22 2671 2680 10.1200/JCO.2004.12.009 1:CAS:528: DC%2BD2cXpsVWktrw%3D 15226334 (Pubitemid 41103755)
21. C.R. Scoggins M.I. Ross D.S. Reintgen, et al. 2006 Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma J Clin Oncol 24 2849 2857 10.1200/JCO.2005.03. 2342 1:CAS:528:DC%2BD28XntV2gsrs%3D 16782924 (Pubitemid 46630585)
22. J.M. Hilari C. Mangas L. Xi, et al. 2009 Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time RT-PCR Ann Surg Oncol 16 177 185 10.1245/s10434-008-0183-9 18982394
23. F. Amersi D.L. Morton 2007 The role of sentinel lymph node biopsy in the management of melanoma Adv Surg 41 241 256 10.1016/j.yasu.2007.05.015 17972569
24. J.M. Thomas 2008 Prognostic false-positivity of the sentinel node in melanoma Nat Clin Pract Oncol 5 18 23 10.1038/ncponc1014 18097453
25. S.A. Rosenberg 2008 Why perform sentinel-lymph-node biopsy in patients with melanoma? Nat Clin Pract Oncol 5 1 10.1038/ncponc1022 18097452
26. Starz H, Siedlecki K, Balda BR, (2004) Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol (3 Suppl): 162S-168S
27. G.W. Carlson D.R. Murray R.H. Lyles, et al. 2003 The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 10 575 581 10.1245/ASO.2003.03.054 12794026 (Pubitemid 40486923)
28. D.J. Dewar B. Newell M.A. Green, et al. 2004 The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement J Clin Oncol 22 3345 3349 10.1200/JCO.2004.12.177 1:STN:280:DC%2BD2cvgs1GhtQ%3D%3D 15310779 (Pubitemid 41103692)
29. A. Govindarajan D.M. Ghazarian D.R. McCready, et al. 2007 Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse Ann Surg Oncol 14 906 912 10.1245/s10434-006-9241-3 17136471 (Pubitemid 46175342)
30. A.C. van Akkooi Z.I. Nowecki C. Voit, et al. 2008 Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes Ann Surg 248 949 955 10.1097/SLA.0b013e31818fefe0 19092339
31. I.M. van der Ploeg B.B. Kroon N. Antonini, et al. 2009 Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node Ann Surg 250 301 304 10.1097/SLA.0b013e3181b1735b 19638903
32. D.L. Morton A.J. Cochran J.F. Thompson 2007 Authors' response to a letter to the editor re: sentinel node biopsy for early-stage melanoma Ann Surg 245 828 829 10.1097/01.sla.0000261157.79250.16 17457182 (Pubitemid 46684119)
33. K. Spanknebel D.G. Coit S.C. Bieligk, et al. 2005 Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis Am J Surg Pathol 29 305 317 10.1097/01.pas.0000152134.36030.b7 15725798 (Pubitemid 40321965)
34. A.H. Chakera B. Hesse Z. Burak, et al. 2009 EANM-EORTC general recommendations for sentinel node diagnostics in melanoma Eur J Nucl Med Mol Imaging 36 1713 1742 10.1007/s00259-009-1228-4 1:CAS:528:DC%2BD1MXht1WhtLzF 19714329